SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: WTDEC who wrote (29012)6/29/1999 11:21:00 PM
From: Henry Niman  Respond to of 32384
 
Walter, LGND was not deleted. Domain Associates will give Ron Evans $25 Million to develop orphan receptors (IR technology) and LGND will develop interesting leads.

Blair said that target identification was one of the few areas where Biotechs could effectively compete with pharma, if sufficient resources were channeled into well defined focused areas.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News